JP Morgan Healthcare Conference, Day Two: Life Technologies, Roche, Agilent, Thermo Fisher, Cepheid, GenMark | GenomeWeb

SAN FRANCISCO (GenomeWeb News) – The second day of this year's JP Morgan Healthcare Conference included presentations from a number of companies in the genomic technology and molecular diagnostic market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.